Home/Filings/4/0001140361-22-012918
4//SEC Filing

Feingold Jay 4

Accession 0001140361-22-012918

CIK 0001782223other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:16 PM ET

Size

4.5 KB

Accession

0001140361-22-012918

Insider Transaction Report

Form 4
Period: 2022-03-31
Feingold Jay
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-03-31+306,930350,680 total
Footnotes (1)
  • [F1]Represents restricted stock units that vest over a four-year period, with 25% vesting on the first anniversary of the grant date, and the remaining 75% vesting in 12 substantially-equal quarterly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001885838

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:16 PM ET
Size
4.5 KB